Neuromodulation is a new approach for mental disorders resistant to usual treatment that is network pathway-oriented and involves the use of several devices. It represents a promising tool in the quest for “precision medicine” and is aligned with the National Insti- tute of Mental Health’s research domain criteria-based approach for the treatment of brain diseases. In this article, we review currently available data on neuromodulation approaches for obsessive-compulsive disorder (OCD). These approaches are repetitive transcranial magnetic stimulation, deep transcranial magnetic stimulation and deep brain stimulation. DBS and, to a lesser degree, transcranial magnetic stimulation, seem to be promising tools for the treatment of resistant and refractory OCD. However, they both remain experimental, and further studies clarifying their long-term outcome and safety are needed. Biomarkers, more precise definitions, and response predictors are also needed and continue to be works-in-progress.
Outcomes with neuromodulation in obsessive- compulsive disorder / Pallanti, Stefano; Marras, Anna; Grassi, Giacomo. - In: PSYCHIATRIC ANNALS. - ISSN 0048-5713. - STAMPA. - (2015), pp. 316-320.
Outcomes with neuromodulation in obsessive- compulsive disorder.
PALLANTI, STEFANO;MARRAS, ANNA;GRASSI, GIACOMO
2015
Abstract
Neuromodulation is a new approach for mental disorders resistant to usual treatment that is network pathway-oriented and involves the use of several devices. It represents a promising tool in the quest for “precision medicine” and is aligned with the National Insti- tute of Mental Health’s research domain criteria-based approach for the treatment of brain diseases. In this article, we review currently available data on neuromodulation approaches for obsessive-compulsive disorder (OCD). These approaches are repetitive transcranial magnetic stimulation, deep transcranial magnetic stimulation and deep brain stimulation. DBS and, to a lesser degree, transcranial magnetic stimulation, seem to be promising tools for the treatment of resistant and refractory OCD. However, they both remain experimental, and further studies clarifying their long-term outcome and safety are needed. Biomarkers, more precise definitions, and response predictors are also needed and continue to be works-in-progress.I documenti in FLORE sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.